What is the appropriate prescription and dosing regimen for acrodermatitis enteropathica?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Acrodermatitis Enteropathica: Prescription and Dosing

Prescribe lifelong oral elemental zinc at 3 mg/kg/day for acrodermatitis enteropathica, adjusting the dose based on plasma zinc levels. 1

Dosing Regimen

  • Standard dose: 3 mg/kg per day of elemental zinc (Zn2+) given orally 1
  • Duration: Lifelong therapy is required for hereditary acrodermatitis enteropathica 1
  • Formulation preference: Organic zinc compounds (zinc gluconate, zinc histidinate, or zinc orotate) are better tolerated than inorganic forms (zinc sulfate or zinc chloride) 1

The ESPEN 2022 micronutrient guidelines provide a Grade 0 recommendation with 94% strong consensus for this dosing approach, making it the most authoritative guidance available 1.

Monitoring and Dose Adjustment

  • Monitor plasma zinc levels to guide dose adjustments 1
  • Measure CRP and albumin simultaneously when checking zinc levels, as inflammation (CRP >20 mg/L) significantly decreases plasma zinc and complicates interpretation 1
  • Target zinc level: Normal range is 60-110 µg/dL 2

Clinical Response Timeline

  • Rapid improvement expected: Skin lesions typically resolve within 2-3 weeks of initiating therapy 2, 3
  • Complete resolution of dermatitis, diarrhea, and alopecia occurs with appropriate supplementation 4
  • Therapeutic efficacy rate: 91.4% of patients respond to zinc supplementation at 1-3 mg/kg/day 4

Important Caveats

Metabolic Disorders

  • Zinc supplementation may be ineffective in patients with acrodermatitis enteropathica associated with underlying metabolic disorders 4
  • Address the underlying metabolic perturbations first in these cases 4

Acquired vs. Hereditary Forms

  • Acquired zinc deficiency (from malnutrition, parenteral nutrition without adequate zinc, malabsorption) requires 0.5-1 mg/kg per day for 3-4 months, not lifelong therapy 1
  • Hereditary acrodermatitis enteropathica (ZIP4 transporter mutation) requires lifelong treatment 1

Toxicity Prevention

  • Avoid exceeding recommended doses, as zinc toxicity symptoms appear when ingestion exceeds 1-2 g 1
  • Acute toxicity causes nausea and vomiting 3
  • Chronic zinc toxicity can cause copper deficiency and requires treatment with copper sulfate 1

Practical Prescribing Example

For a 10 kg child with acrodermatitis enteropathica:

  • Dose: 30 mg elemental zinc daily (3 mg/kg × 10 kg)
  • Formulation: Zinc gluconate or zinc sulfate syrup, divided into 2-3 doses daily 5
  • Follow-up: Check plasma zinc levels after 1-2 months, then every 6-12 months 1

References

1
Guideline

espen micronutrient guideline.

Clinical Nutrition, 2022

Related Questions

Can total parenteral nutrition cause a slowly developing rash on the arms over several days?
What is the recommended acyclovir dosage for children with chickenpox, including adjustments for immunocompromised patients and those with renal impairment?
In a patient without signs of infection (no pus, redness, or fever) who experiences shooting pain and mild swelling away from the thread insertion site, what is the second most likely cause?
What does enlargement of the subarachnoid space mean?
What are endocannabinoids?
What is the appropriate route of administration for a 5 mg dose of olanzapine?
How should a foreign body reaction and inflammation causing pain five weeks after placement of polydioxanone (PDO) threads be treated when there are no signs of infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.